tirzepatide forms (Mounjaro) for the Treatment of Type 2 Diabetes Mellitus Tirzepatide, a New Era of

Key Takeaways CVS Caremark covers Wegovy on approximately 18% of commercial employer-sponsored plans as of Q1 2026, typically requiring step therapy and prior authorization Most CVS Caremark plans place Wegovy on Tier 3 (preferred brand) or exclude it entirely, with monthly copays ranging from $25 to $1,349 depending on plan design Prior authorization approval rates for Wegovy through CVS Caremark average 34% on first submission, with denials most commonly citing failure to meet BMI thresholds or lack of documented lifestyle intervention Compounded semaglutide costs $297 to $347 per month through platforms like FormBlends and does not require insurance coverage or prior authorization Direct answer (40-60 words) CVS Caremark covers Wegovy on a minority of commercial plans in 2026, with coverage limited to patients meeting strict criteria: BMI 30+ (or 27+ with comorbidity), documented 90-day lifestyle intervention, and successful completion of step therapy

10.3390/biomedicines10040891 Biomedicines 165 WeiC

The body thinks it has enough hormone

Note the tears at the insertion point